| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.49▼ | 9.49▼ | 9.54▼ | 9.83▼ | 10.96▼ |
| MA10 | 9.50▼ | 9.55▼ | 9.58▼ | 10.43▼ | 11.70▼ |
| MA20 | 9.51▼ | 9.58▼ | 9.75▼ | 11.39▼ | 10.48▼ |
| MA50 | 9.54▼ | 9.77▼ | 10.07▼ | 11.67▼ | 8.45▲ |
| MA100 | 9.57▼ | 10.19▼ | 11.00▼ | 10.51▼ | 5.30▲ |
| MA200 | 9.74▼ | 11.10▼ | 12.06▼ | 9.21▲ | 4.00▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.001▼ | 0.003▲ | -0.279▼ | -0.294▼ |
| RSI | 42.238▼ | 39.843▼ | 39.318▼ | 32.673▼ | 47.280▼ |
| STOCH | 38.016 | 25.315 | 28.786 | 9.842▼ | 46.228 |
| WILL %R | -93.333▼ | -84.127▼ | -90.991▼ | -97.429▼ | -77.166▼ |
| CCI | -101.558▼ | -87.615 | -113.978▼ | -108.695▼ | -65.927 |
|
Monday, October 05, 2026 01:44 AM
LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at the ...
|
|
Wednesday, September 30, 2026 10:15 AM
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “we” or “us” or “IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the closing of its previously announced underwritten ...
|
|
Tuesday, September 29, 2026 06:34 AM
Immix Biopharma, Inc. (NASDAQ:IMMX) reported interim data from its NEXICART-2 Phase 2 clinical trial of NXC-201 in patients with relapsed or refractory AL amyloidosis. According to the company, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/10/26 | 9.50 | 9.69 | 9.40 | 9.49 | 1,382,066 |
| 06/10/26 | 10.20 | 10.20 | 9.515 | 9.64 | 1,211,672 |
| 05/10/26 | 9.71 | 10.33 | 9.55 | 10.13 | 1,597,501 |
| 02/10/26 | 10.35 | 10.37 | 9.48 | 9.68 | 2,546,281 |
| 01/10/26 | 10.25 | 10.475 | 9.86 | 10.23 | 1,648,321 |
| 30/09/26 | 10.61 | 11.25 | 10.3925 | 10.405 | 2,396,338 |
| 29/09/26 | 11.64 | 11.848 | 10.07 | 10.54 | 5,751,517 |
| 28/09/26 | 10.82 | 11.84 | 10.70 | 11.47 | 995,932 |
| 25/09/26 | 11.78 | 11.9899 | 10.82 | 10.97 | 1,827,807 |
| 24/09/26 | 11.87 | 11.97 | 11.185 | 11.70 | 1,535,650 |
|
|
||||
|
|
||||
|
|